Insider Ledger

LAB insider buying and SEC filings, explained

Standard Biotools Inc. · CIK 1162194

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Pharmaceutical Preparations
State of incorporation
DE
Fiscal year end
Dec 31
Former names
FLUIDIGM CORP

Insider activity in the last 12 months

Bought
$14.4M
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Dec 2–4, 2025Purchase (code P)Eli Casdin (Director and 10% owner) bought 350,000 shares indirectly between Dec 2, 2025 and Dec 4, 2025 at about $1.44 ($503K), reported as a purchase (code P). Indirect holdings up <1% to 72,100,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.SEC filing
Filed Dec 4, 2025
Nov 24–25, 2025Purchase (code P)Eli Casdin (Director and 10% owner) bought 7,700,000 shares indirectly between Nov 24, 2025 and Nov 25, 2025 at about $1.30 ($10.0M), reported as a purchase (code P). Indirect holdings up 12% to 71,750,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.SEC filing
Filed Nov 26, 2025
Nov 18–20, 2025Purchase (code P)Eli Casdin (Director and 10% owner) bought 1,075,000 shares indirectly between Nov 18, 2025 and Nov 20, 2025 at about $1.28 ($1.4M), reported as a purchase (code P). Indirect holdings up 2% to 64,050,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.SEC filing
Filed Nov 20, 2025
Nov 13–17, 2025Purchase (code P)Eli Casdin (Director and 10% owner) bought 925,000 shares indirectly between Nov 13, 2025 and Nov 17, 2025 at about $1.22 ($1.1M), reported as a purchase (code P). Indirect holdings up 1% to 62,975,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.SEC filing
Filed Nov 17, 2025
Nov 7–12, 2025Purchase (code P)Eli Casdin (Director and 10% owner) bought 1,175,000 shares indirectly between Nov 7, 2025 and Nov 12, 2025 at about $1.17 ($1.4M), reported as a purchase (code P). Indirect holdings up 2% to 62,050,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners.SEC filing
Filed Nov 12, 2025

27 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

FiledItemsTagSource
Nov 3, 2026, 8:23 AM ET
8-K
Reg FD disclosure (Item 7.01)SEC filing

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow LAB in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app